Subscribe to RSS
DOI: 10.1055/s-2008-1039217
© Georg Thieme Verlag KG Stuttgart · New York
Long-term Survival after Surgery for Acute Coronary Syndromes in Relation to Perioperative Troponin T Release and Angina Class – A Prospective Study in 200 Patients
Publication History
received Sept. 10, 2008
Publication Date:
27 March 2009 (online)
Abstract
Objective: Patients with acute coronary syndrome have an increased risk of cardiac death or myocardial infarction after urgent coronary artery bypass surgery (CABG). Symptoms and signs of ongoing ischemia, such as elevated cardiac troponin T and angina at rest at the time of the operation identify patients at particular risk of early death, but the impact of these parameters on long-term survival is poorly investigated. Methods: Two hundred patients, 100 with acute coronary syndrome and 100 with stable angina pectoris, underwent primary isolated CABG. Troponin T levels were assayed immediately before the operation and at 64 hours after the aortic cross-clamp had been removed. The severity of the patients' unstable symptoms was classified according to Braunwald. Early outcome and long-term survival were analyzed. Results: Among the unstable patients 3 deaths occurred within 30 days of the operation, and there were 12 late deaths. In the control group there were no early and 19 late deaths. The patients were followed up for 6.5 years (0–7.7 years), a total of 1 294 patient years. The cumulative long-term survival was 85 % for the unstable and 81 % for the stable patients (p = 0.75). Freedom from cardiac death was 92 % in unstable and 94 % in stable patients. Five unstable and one of the stable patients suffered postoperative myocardial infarction (p = 0.01). A troponin T level > 0.1 µg/L immediately prior to the operation was associated with an increased need for postoperative pharmacological inotropic support (p < 0.001) and intra-aortic balloon counterpulsation (p = 0.004). Symptoms and signs of ongoing ischemia (angina at rest and elevated troponin T immediately prior to the operation) had no predictive value for long-term survival. Conclusion: In patients with acute coronary syndrome, parameters such as elevated troponin T and angina at rest herald an increased risk of postoperative myocardial infarction and indicate the need for pharmacological and mechanical inotropic support but have no bearing on long-term survival.
Key words
coronary bypass surgery - myocardial protection - heart disease
References
- 1 James S K, Lindback J, Tilly J, Siegbahn A, Venge P, Armstrong P. et al . Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO‐IV substudy. J Am Coll Cardiol. 2006; 48 1146-1154
- 2 Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E, Wallentin L. 5-year outcomes in the FRISC‐II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet. 2006; 368 998-1004
- 3 Solodky A, Behar S, Boyko V, Battler A, Hasdai D. The outcome of coronary artery bypass grafting surgery among patients hospitalized with acute coronary syndrome: the Euro Heart Survey of acute coronary syndrome experience. Cardiology. 2005; 103 44-47
- 4 Hirsch A, Windhausen F, Tijssen J G, Verheugt F W, Cornel J H, de Winter R J. Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study. Lancet. 2007; 369 827-835
- 5 Fremes S E, Goldman B S, Christakis G T, Ivanov J, Weisel R D, Salerno T A. et al . Current risk of coronary bypass for unstable angina. Eur J Cardiothorac Surg. 1991; 5 235-242 242-243
- 6 Carrier M, Pelletier L C, Martineau R, Pellerin M, Solymoss B C. In elective coronary artery bypass grafting, preoperative troponin T level predicts the risk of myocardial infarction. J Thorac Cardiovasc Surg. 1998; 115 1328-1334
- 7 Machler H, Gombotz H, Sabin K, Metzler H. Troponin T as a marker of perioperative myocardial cell damage. Adv Pharmacol. 1994; 31 63-73
- 8 Burlina A, Zaninotto M, Secchiero S, Rubin D, Accorsi F. Troponin T as a marker of ischemic myocardial injury. Clin Biochem. 1994; 27 113-121
- 9 Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. BMJ. 1996; 313 262-264
- 10 Seino Y, Tomita Y, Takano T, Hayakawa H. Early identification of cardiac events with serum troponin T in patients with unstable angina. Lancet. 1993; 342 1236-1237
- 11 Cannon C P, McCabe C H, Stone P H, Rogers W J, Schactman M, Thompson B W. et al . The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in myocardial ischemia. J Am Coll Cardiol. 1997; 30 133-140
- 12 Olatidoye A G, Wu A H, Feng Y J, Waters D. Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies. Am J Cardiol. 1998; 81 1405-1410
- 13 Patel D J, Holdright D R, Knight C J, Mulcahy D, Thakrar B, Wright C. et al . Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram. Heart. 1996; 75 222-228
- 14 Braunwald E. Unstable angina. A classification. Circulation. 1989; 80 410-414
- 15 Bjessmo S, Ivert T. Troponin-T in patients with unstable and stable angina pectoris undergoing coronary bypass surgery. Thorac Cardiovasc Surg. 2000; 48 140-144
- 16 Giri S, Waters D D. Pathophysiology and initial management of the acute coronary syndromes. Curr Opin Cardiol. 1996; 11 351-360
- 17 Yusuf S, Zhao F, Mehta S R, Chrolavicius S, Tognoni G, Fox K K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001; 345 494-502
- 18 Yusuf S, Mehta S R, Zhao F, Gersh B J, Commerford P J, Blumenthal M. et al . Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation. 2003; 107 966-972
Dr. MD, PhD Staffan Bjessmo
The Cardiothoracic Surgery Unit
Department of Molecular Medicine and Surgery
Karolinska Institutet
17176 Stockholm
Sweden
Phone: + 46 8 51 77 08 22
Fax: + 46 8 32 27 01
Email: staffan.bjessmo@karolinska.se